Discontinued — last reported Q2 '21
Medtronic Unrecognized Tax Benefits - Impacting Effective Tax Rate remained flat by 0.0% to $2.70B in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.70B to $2.70B.
An increase suggests higher tax uncertainty, while a decrease may indicate the resolution of tax audits or the expiration of statutes of limitations.
This represents the portion of tax positions taken by the company that have not been recognized in the financial stateme...
Highly dependent on the company's global tax footprint and audit environment; peers with similar international operations show comparable levels of tax uncertainty.
unrecognized_tax_benefits_impacting_etr| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.60B | $1.60B | $1.60B | $1.60B | $2.40B | $2.40B | $2.60B | $2.60B | $2.60B | $2.70B | $2.70B | $2.70B | $2.70B | $2.70B | $2.70B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +50.0% | +0.0% | +8.3% | +0.0% | +0.0% | +3.8% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | +50.0% | +50.0% | +62.5% | +8.3% | +8.3% | +3.8% | +3.8% | +3.8% | +0.0% | +0.0% | +0.0% |